New Data From PROMMIS Study Highlights The Power Of SKY92 In Identifying High-Risk Multiple Myeloma Patients
New Data From PROMMIS Study Highlights The Power Of SKY92 In Identifying High-Risk Multiple Myeloma Patients . (MENAFN - PR Newswire) 
  
  
 
 
 
 
 
 ROTTERDAM, the Netherlands and SAN DIEGO, Dec. 7, 2024 /PRNewswire/ -- SkylineDx, an innovative diagnostics company specializing in the research and ...
América - MenaFN
Jordania
https://menafn.com/images/Menafn_SmallLogo.jpg
https://menafn.com/1108967434/New-Data-From-PROMMIS-Study-Highlights-The-Power-Of-SKY92-In-Identifying-High-Risk-Multiple-Myeloma-Patients
2024-12-07
rss
(MENAFN - PR Newswire) 
  
  
 
 
 
 
 
 ROTTERDAM, the Netherlands and SAN DIEGO, Dec. 7, 2024 /PRNewswire/ -- SkylineDx, an innovative diagnostics company specializing in the research and ...
New Data From PROMMIS Study Highlights The Power Of SKY92 In Identifying High-Risk Multiple Myeloma Patients